Havana, Cuba.- The 3rd phase of clinical trials to evaluate the efficacy and safety of the NeuralCIM neuroprotective drug in patients with mild or moderate Alzheimer’s amnesic variant is being carried out in Sancti Spiritus, medical specialists reported on Monday. Dr. Iralys Benitez, the territorial coordinator of the research, told local media that the trial […]